Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Local Suppression of Tumor Necrosis Factor Alpha Improves Experimental Herpetic Keratitis
Wasmuth S.1,2, Bauer D.1, Yang Y.1, Steuhl K. P.2, Heiligenhaus A.1
1Ophtha-Lab and Department of Ophthalmology at St. Franziskus Hospital, Muenster; 2Department of Ophthalmology, University of Duisburg-Essen
Purpose: In this study we investigated if a local treatment with antisense oligonucleotides (ASON) targeting TNF alpha is useful to improve the course of herpes simplex keratitis (HSK).
Method: Cell suspensions prepared from spleens or regional lymph nodes from herpes simplex virus-1 infected mice were incubated with 0.5 to 20 µM of ASON, unrelated control oligonucleotides (CON) or medium. 24 h later, the cell culture supernatants were examined by ELISA for their content of TNF alpha. FITC-ASON were used to study the uptake of the oligonucleotides into the cells by FACScan analysis. In vivo, FITC-ASON or unbound FITC were injected into the corneas of BALB/c mice. After different periods of time, paraffin-sections of these eyes were examined by fluorescence microscopy. On day 0 mice were infected corneally with 100000 PFU HSV-1. On days -1, 1 and 4 the animals were treated topically with ASON targeting TNF-alpha. Mice from the control groups received CON or buffer. All animals were examined daily.
Results: The in vitro production of TNF alpha by cells from spleens and regional lymph nodes was strongly reduced following ASON treatment. In vivo, after a single injection of